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Ergosterol synthesis is essential for cellular growth and viabil-
ity of the budding yeast Saccharomyces cerevisiae, and intracel-
lular sterol distribution and homeostasis are therefore highly
regulated in this species. Erg25 is an iron-containing C4-methyl
sterol oxidase that contributes to the conversion of 4,4-dimeth-
ylzymosterol to zymosterol, a precursor of ergosterol. The
ERG29 gene encodes an endoplasmic reticulum (ER)-associated
protein, and here we identified a role for Erg29 in the methyl
sterol oxidase step of ergosterol synthesis. ERG29 deletion
resulted in lethality in respiring cells, but respiration-incompe-
tent (Rho or Rho0) cells survived, suggesting that Erg29 loss
leads to accumulation of oxidized sterol metabolites that affect
cell viability. Down-regulation of ERG29 expression in erg29
cells indeed led to accumulation of methyl sterol metabolites,
resulting in increased mitochondrial oxidants and a decreased
ability of mitochondria to synthesize iron–sulfur (Fe-S) clusters
due to reduced levels of Yfh1, themammalian frataxin homolog,
which is involved in mitochondrial iron metabolism. Using a
high-copy genomic library, we identified suppressor genes that
permitted growth of erg29 cells on respiratory substrates, and
these included genes encoding themitochondrial proteins Yfh1,
Mmt1, Mmt2, and Pet20, which reversed all phenotypes associ-
ated with loss of ERG29. Of note, loss of Erg25 also resulted in
accumulation of methyl sterol metabolites and also increased
mitochondrial oxidants and degradation of Yfh1. We propose
that accumulation of toxic intermediates of the methyl sterol
oxidase reaction increases mitochondrial oxidants, which affect
Yfh1 protein stability. These results indicate an interaction
between sterols generated by ER proteins and mitochondrial
iron metabolism.
Mitochondria house two iron-consuming biosynthetic path-
ways, heme and iron–sulfur (Fe-S)2 cluster synthesis. In yeast,
Fe-S synthesis is the essential iron-consuming process, as yeast
can survive without heme or respiration but not without Fe-S
cluster synthesis (1, 2).Many of the genes involved in Fe-S clus-
ter synthesis and particularly in the mitochondrial synthesis
and export of Fe-S clusters are highly conserved in all
eukaryotes. Yfh1, the yeast equivalent of mammalian frataxin,
plays an important role in the early steps of Fe-S cluster synthe-
sis (3–13). Whereas the exact role has not been defined, loss of
Yfh1 results in severely compromised Fe-S cluster synthesis
and decreased mitochondrial function. Loss of Yfh1, as with
mutations in genes in the early steps of mitochondrial Fe-S
cluster synthesis, results in increased deposits of insoluble iron,
“nanoparticles,” within mitochondria (11). The generation of
these nanoparticles results in concomitant oxidant radical for-
mation, leading to loss of mitochondrial DNA. YFH1 was ini-
tially identified through a genetic screen for yeast mutants that
were unable to grow on low-ironmedium (4). Babcock et al. (4)
generated a mutant, bm-8, which was suppressed by a high-
copy plasmid that contained YFH1. YFH1 was acting as a high-
copy suppressor and was not allelic to the mutation in bm-8.
The bm-8mutant allele was amissensemutation inYMR134W,
which encoded for a protein of unknown function. Moretti-
Almeida et al. (14) reported that a temperature-sensitive allele
of YMR134W showed low mitochondrial iron accumulation at
the restrictive temperature alongwith defects in ergosterol syn-
thesis. Here, we report a detailed description of YMR134W,
herein referred to as ERG29. We determined that deletion of
ERG29 resulted in lethality in respiring cells, but cells that had
lost the ability to respire (Rho or Rho0) could survive and that
ERG29 encodes an endoplasmic reticulum (ER) protein that
plays a role in sterol synthesis at the methyl sterol oxidase step.
We determined that in the absence of ERG29, methyl sterol
metabolites accumulate and result in a decreased ability of
mitochondria to synthesize Fe-S clusters.We further show that
decreased Fe-S cluster synthesis is due to a dramatic reduction
in Yfh1. The effects of ERG29 loss can be exacerbated by
increased mitochondrial iron import or decreased by overex-
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pression ofmitochondrial iron exporter geneMMT1 orMMT2
or by overexpression of YFH1 or PET20, a nuclear gene that
encodes a mitochondrial protein involved in protecting mito-
chondria from oxidant damage (15).
Results
Deletion of ERG29 affects sterol synthesis
Erg25 is a methyl sterol oxidase, which is an essential oxo-
diiron–containing enzyme located in the ER (16–18). In a com-
plex set of reactions, Erg25 along with two other enzymes
(Erg26 and Erg27) catalyzes the demethylation of 4,4-dimeth-
ylzymosterol (4,4-DMZ) to zymosterol. Preliminary studies
showed that when cells with a missense mutation in
YMR134W/ERG29were placed on low iron, they had an altered
sterol pattern, similar to that seen in mutants in ERG25 (data
not shown). This finding led us to examine the effects of dele-
tion of ERG29. Previous studies showed that ERG29 was lethal
in respiring cells (19). To determine the function of Erg29, we
generated a ERG29 deletion strain that contained a plasmid
expressing carboxyl-terminally His-tagged Erg29 whose ex-
pression was under the control of either the -estradiol pro-
moter (turned on in the presence of -estradiol, pGEV) or the
GAL1promoter (on in the presence of galactose) (Table 1). This
two-plasmid system allows for independent regulation of
expression via growth in glucose with the addition of -estra-
diol (no carbon source change) or via growth in galactose to
permit expression and then shifted to glucose to suppress
expression (20). This system also allows for tightly regulated
-estradiol–titrated expression from low to extremely high lev-
els. Cells with a deletion in ERG29 grown in -estradiol were
viable (Fig. 1A, middle), whereas the absence of -estradiol
resulted in a severe growth defect (Fig. 1A, right, top left quad-
rant), which over time led to the generation of small colonies.
These small colonies were able to grow but were shown to be
respiration-incompetent, as they were unable to grow onYPGE
(Fig. 1A, right, top right quadrant compared with left, top right
quadrant). We noted growth of erg29 p-estradiol-ERG29
cells on YPGE without -estradiol (Fig. 1A, left, top left quad-
rant). As those cells were unable to grow on YPD () -estra-
diol (Fig. 1A, right, top left quadrant), we attribute the growth
on YPGE to the absence of glucose-mediated repression of the
GAL1 promoter in the pGEV system (20).We utilized galactose
regulation of the erg29p-estradiolGAL1ERG29 strain to
examine the effects of loss of Erg29 on sterol synthesis.
erg29pGAL1ERG29 cells grown in galactose had some
increase in the levels of 4,4-DMZ and 4-methyl fecosterol and
decreased levels of ergosterol compared with WT cells; how-
ever, in glucose-containingmedium,erg29pGAL1ERG29 cells
showed an increase in intermediate sterols and a corresponding
decrease in zymosterol and ergosterol (Fig. 1B). We confirmed
that growth in glucose resulted in the loss of Erg29-His protein
(Fig. 1C).We note thatWT cells grown in glucose accumulated
more zymosterol than when grown in galactose. We do not
know the reason for this observation. We hypothesize that the
altered sterols seen in galactose-grown erg29pGAL1ERG29
cells reflect decreased function of the epitope-tagged Erg29.
We confirmed this hypothesis by transforming the erg29p-
estradiolGAL1ERG29 strain with a plasmid containing non-
tagged ERG29 under its endogenous promoter. Sterol anal-
ysis revealed lower levels of methyl sterol intermediates and
increased zymosterol and ergosterol in cells expressing
nontagged Erg29 (Fig. 1D). This supports the hypothesis that
the epitope tag reduced the function of Erg29. We also deter-
mined that the untagged Erg29 functioned better in comple-
menting the loss of Erg29 (Fig. 1D,  pYcp ERG29  -estra-
diol (hatched gray bar) comparedwith-estradiol alone (gray
bar)).
The sterol pattern observed in ERG29 “shut-off” cells was
similar to that seen in cells with mutations in ERG25 (18). To
more closely examine the similarities in sterol profiles, we
generated a ERG25 deletion strain expressing a -estradiol
pGAL1ERG25 similar to the “ERG29 shut-off” system.
erg25pGAL1ERG25 cells grown in galactose had some
increase in the levels of 4,4-DMZ and 4-methyl fecosterol and
decreased levels of ergosterol compared withWT cells; how-
ever, in glucose-containing medium erg25pGAL1ERG25
cells showed a dramatic increase in 4,4-DMZ and a corre-
sponding decrease in zymosterol and ergosterol (Fig. 1E).
We confirmed that growth in glucose resulted in the loss of
Erg25 protein (Fig. 1C). The sterol pattern seen in glucose-
grown erg25pGAL1ERG25 cells appears similar to that in
erg29pGAL1ERG29 cells, although we consistently observed
higher levels of the methyl sterol intermediates, such as
4-methyl fecosterol (see Fig. 1B) and 4-carboxyzymosterol in
erg29pGAL1ERG29 cells (data not shown). That the loss of
ERG29 affects the methyl sterol oxidase reaction is supported
by the observation that overexpression of ERG25, through
transformation with a high-copy plasmid permitted erg29
cells to survive (Fig. 2A). In contrast, transformation with a
high-copy ERG26 plasmid, which encodes the subsequent
enzyme in the methyl sterol oxidase reaction (21), did not.
Together, the results support the hypothesis that the loss of
ERG29 affects the methyl sterol oxidase reaction in which
Erg25 is the first enzyme in the reaction. These results suggest
that the “shut-off” of ERG29 specifically affects the Erg25 reac-
tion and not another enzyme in the methyl sterol oxidase reac-
tion. Erg25 is localized to the endoplasmic reticulum (18). We
generated a MET3-regulated ERG29-GFP plasmid and trans-
formed it intoWTorerg29pGAL1ERG29 cells.We confirmed
that the carboxyl-tagged Erg29-GFP complemented the loss of
ERG29 (Fig. 2B) and confirmed that Erg29-GFP is localized to
Table 1
Plasmids used in this study
Plasmid Source/Reference
pGEV(Gal4:EV:VP16) HIS3 from Ref. 20
pGAL1ERG29 TRP1 (this study)
pGAL1ERG25 TRP1 (this study)
pYCpERG29 URA3 (this study)
pMET3ERG29-GFP URA3 (this study)
pYEpERG25 URA3 from Ref. 66
pYEpERG26 URA3 from Ref. 45
pMMT1 LEU2 from Ref. 25
pMMT2 LEU2 from Ref. 25
pYFH1 LEU2 from Ref. 5
pMET3YFH1 LEU2 from Ref. 5
pPET20 LEU2 (this study)
pMET3MRS3 LEU2 from Ref. 25
pMET3MMT1 URA3 from Ref. 25
pMMT1/2 URA3 from Ref. 25
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the endoplasmic reticulum (Fig. 2C) similar to that reported in
a previous genomic epitope tag study (22).
Loss of respiration affects the sterol pattern inerg29 cells
As described in Fig. 1, loss of respiration can permit erg29
cells to survive as Rho0 cells. Based on this result, we examined
whether there were changes in the sterol pattern in Rho0 cells.
We used ethidiumbromide to generate Rho0WTcells and then
deleted ERG29 to generate erg29 Rho0 cells. Making cells
Rho0 alone did not affect ergosterol synthesis, whereas the loss
of ERG29 in Rho0 cells showed diminished ergosterol synthesis
and increased intermediate sterols compared with WT Rho0
cells (Fig. 3A); however, the levels of accumulated intermedi-
ates were reduced in erg29 Rho0 cells compared with
erg29pGAL1ERG29 grown in glucose (Fig. 1B) or in the
absence of -estradiol (Fig. 1C). Further, the amount of ergos-
terol synthesized in erg29 Rho0 cells was increased compared
witherg29pGAL1ERG29 grown in glucose or in the absence of
-estradiol. These results suggest that mitochondrial respira-
tion ormitochondrial oxidants affect ergosterol synthesis in the
absence of ERG29.
To determine whether iron limitation affected sterol synthe-
sis, WT Rho0 and erg29 Rho0 cells were grown in medium
made iron-limited by the iron chelator bathophenanthroline
sulfonate (BPS). erg29 Rho0 cells grew poorly (BPS with 0–4
M iron (BPS(0) to BPS(4)) but equal to WT Rho0 cells with
increased iron (BPS(100)) (Fig. 3B). As erg29 Rho0 cells grew
poorly if grown on iron-limitedmedium for extended times, we
grew WT Rho0 and erg29 Rho0 cells in iron-limited medium
for 4 h to examine whether limiting iron affected sterol synthe-
sis. erg29 Rho0 cells still showed increased intermediate ste-
rols (4,4-DMZ and 4-methyl fecosterol) and reduced zymos-
Figure 1. Loss of ERG29 results in loss of the mitochondrial genome and increased levels of 4,4-DMZ and 4-methyl fecosterol. A, erg29p-
estradiolGAL1ERG29 (Rho or Rho0 (spontaneous Rho0)) containing empty vector pYCp or pYCpERG29 cells were grownon YPGE or YPDplates in the presence
or absence of -estradiol for 4 days. B, WT (DY1457p-estradiolGAL1 vector) and erg29p-estradiolGAL1ERG29 were grown in galactose or glucose for 16 h,
sterols were extracted, and sterol analysis was performed usingGC/MS as described under “Materials andmethods.” The data are expressed as the percentage
of total sterols. Error bars, S.D. n 3. C, Western blot analysis of Erg29-HIS or Erg25 protein levels in galactose and glucose was performed using His6 antibody
or Erg25 antibody as describedunder “Materials andmethods”. Dpm1, an ERprotein,was used as a load control.n 3. A representative blot is shown. The ratio
of Erg29 or Erg25 to Dpm1 was determined using Bio-Rad ImageLabTM software. D, erg29p-estradiolGAL1ERG29 containing either empty vector or
pYCpERG29 cells was grown in glucose in the absence or presence of -estradiol for 16 h, and sterol analysis was performed as described in B. The data are
expressed as the percentage of total sterols. Error bars, S.D. of four replicates.White bars, no Erg29;white hatched bars, ERG29 expressed under its endogenous
promoter; gray bars, -estradiol ERG29 expression; gray larger hatched bars, -estradiol ERG29 expression and ERG29 expressed under its endogenous
promoter. E, WT (DY1457p-estradiolGAL1 empty vector) and erg25 pGALERG25 cells were grown in galactose- or glucose-containing medium for 16 h as in
B, and sterol analysis was performed as described. The erg25 samples were prepared, and sterol analysis was done in the same experiment as B to contrast
erg29 and erg25; therefore, the WT data shown is the same in B and E. The data are expressed as the percentage of total sterols. Error bars, S.D. n 3.
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terol and ergosterol synthesis compared with WT Rho0 cells
(Fig. 3C). These results demonstrate that short-term growth in
iron-limited medium did not affect the altered sterols seen in
erg29 cells.
Loss of Erg29 affects themethyl sterol oxidase reaction
erg29 Rho0 cells were much more sensitive to conditions
that affected the methyl sterol oxidase reaction than WT Rho0
cells. Incubation of cells with cobalt has been shown to inhibit
the enzyme activity of oxo-diiron–containing Erg25 in
both Saccharomyces cerevisiae and Cryptococcus neofor-
mans, leading to a hyperaccumulation of 4,4-DMZ and
decreased levels of zymosterol (23). The addition of 1.0 mM
cobalt to WT Rho0 cells had little effect on viability, whereas
erg29 Rho0 cells showed a loss of viability (Fig. 3D). Fur-
ther, we utilized the Erg25 inhibitor 6-amino-2-n-pentylth-
iobenzothiazole (APB) to assess growth of erg29 Rho0 cells.
WT Rho0 cells showed some toxicity at 60 M APB, whereas
erg29 Rho0 cells showed toxic effects at 20 M (Fig. 3E).
These results support the view that loss of ERG29 increases
the sensitivity of Erg25 to agents known to affect the Erg25
reaction. Together, these results strongly support the hy-
pothesis that Erg29 functions in the Erg25 methyl sterol
oxidase reaction and that mitochondrial respiration affects
ergosterol synthesis.
Identification of genetic suppressors of ERG29
We took a genetic approach to examine the mechanism of
toxicity due to loss of ERG29. As loss of ERG29 results in death
when cells are grown in respiratory medium, we used a high-
copy genomic library (LEU2) to identify suppressors that would
permit growth of erg29 cells on glycerol-ethanol (GE). We
transformed our erg29YCpERG29(URA3) strain with a
genomic library. We then selected for loss of YCpERG29 on
5-fluoroorotic acid and identified surviving colonies that
could grow on GE. As expected, several recovered plasmids
that allowed erg29 Rho cells to grow on GE contained the
ERG29 gene (data not shown). In addition, we foundMMT2,
YFH1, and PET20 as high-copy suppressors. That we did not
recover ERG25 as a high-copy suppressor suggests that our
screen was not saturated. We confirmed that overexpression
of MMT2, YFH1, and PET20 permitted ERG29 shut-off
(erg29pGAL1ERG29) cells to grow on glucose (Fig. 4A). Bab-
cock et al. (4) initially identified YFH1 as a high-copy suppres-
sor of the missense mutant Erg29 (bm-8) (4). Our results show
that YFH1 can also partially suppress the growth defect of
erg29 cells. MMT2 encodes a mitochondrial iron exporter,
which is a member of the family of cation diffusion facilitators
(24, 25). MMT2 has a paralogue, MMT1. We did not find
MMT1 in our screen, but we confirmed that overexpression of
MMT1 would permit erg29 cells to grow as Rho (Fig. 4A).
PET20 is a nuclear gene that encodes a mitochondrial protein,
which when deleted leads to increased sensitivity to oxidant
stress (15). All of the plasmids that permitted growth of erg29
cells also affected the erg29 sterol pattern (Fig. 4B). Overex-
pression of these genes did not normalize the sterol pattern of
ERG29 shut-off cells but did reduce the levels of 4,4-DMZ and
4-methyl fecosterol and concomitantly increased the levels of
zymosterol and ergosterol.
The finding that the overexpression of mitochondrial iron
exporter genes MMT1 and MMT2 preserved the respiratory
activity of a erg29 led us to examine the effect of either dele-
tion or overexpression of the mitochondrial iron importer
genesMRS3 andMRS4. Deletion ofMRS3 andMRS4 together
but not singly permitted erg29 cells to grow on GE medium
(Fig. 5A, right plate, bottom panels). We observed that overex-
pression of MRS3 in mrs3mrs4 cells did not affect viability
(Fig. 5A, left plate, top panels), whereas overexpression ofMRS3
in mrs3mrs4erg29 cells resulted in a loss of viability on GE
medium (Fig. 5A, left plate, bottompanels). Indeed, overexpres-
sion of MRS3 in erg29 Rho0 cells led to increased levels of
4,4-DMZ and 4-methyl fecosterol and decreased zymosterol
and ergosterol (Fig. 5B). The effects ofMRS3were suppressed if
the mitochondrial iron exporter MMT1 was overexpressed at
the same time. These results suggest a connection between
mitochondrial iron levels, loss of viability, and high levels of
methyl sterol intermediates.
Loss of ERG29 affects Fe-S cluster synthesis
Increased MRS3 expression affects cell growth of erg29
cells, whereas overexpression of MMT1 or deletion of MRS3/
Figure 2. Erg25 partially suppresses the loss of ER-localized Erg29. A,
erg29p-estradiolGAL1ERG29 transformed with pYEp, pYEpERG25, or
pYEpERG26 was grown in galactose or glucose for 3 days. B, erg29p-
estradiolGAL1ERG29 transformed with pMET3YEp or pMET3ERG29-GFP was
grown in galactose or glucose minus methionine for 2 days. C, WT cells were
transformed with a complementing plasmid containing MET3ERG29-GFP.
The cells were grown to mid-log phase in the absence of methionine and
examined by epifluorescence microscopy as described under “Materials and
methods.” Arrows, typical ER localization surrounding the nucleus and near
theplasmamembrane similar to Erg25 localization (18).DIC, differential inter-
ference contrast.
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MRS4 protects these cells. Similar findings have been reported
in cells with a deletion in YFH1. Most notably, the growth of
yfh1 cells was reduced by overexpression of MRS3 or MRS4
but protected by deletion of these genes (26–29). We con-
firmed that overexpression of MMT1 permitted yfh1 cells to
grow in medium supplemented with iron or H2O2 (Fig. 6A).
Loss of Yfh1 is known to decrease Fe-S cluster synthesis, which
leads to the accumulation of iron in mitochondria as ferric iron
deposits (5, 29–31). Together, these findings suggest that the
accumulation of methyl sterol intermediates may also lead to
loss of mitochondrial Fe-S cluster synthesis. We tested this
hypothesis by measuring the activity of the Fe-S–containing
mitochondrial aconitase in erg29pGAL1ERG29 cells. In the
presence of glucose, ERG29 shut-off, there was a dramatic
decrease in aconitase activity in erg29pGAL1ERG29 cells
compared with WT cells (Fig. 6B). Overexpression of the
high-copy suppressor YFH1, MMT1, MMT2, or PET20 in
erg29pGAL1ERG29 cells grown in glucose resulted in im-
proved aconitase activity.
Lipoate synthase is an Fe-S cluster–containing protein,
which is rapidly degraded in the absence of Fe-S clusters, result-
ing in decreased lipoic acid modifications to mitochondrial
proteins (32–34). Measuring lipoic acid modification on pro-
teins byWestern blotting provides a measure of Fe-S synthesis.
ERG29 shut-off resulted in decreased lipoic acid protein mod-
ifications on pyruvate dehydrogenase (PDH) and oxoketo-
glutarate dehydrogenase (KDH) (35, 36), whereas overexpression
of YFH1, MMT1, MMT2, or PET20 in erg29pGAL1ERG29
cells resulted in a partial recovery of lipoic acid modifications
(Fig. 6C). Together, these results confirm that loss of ERG29
affects mitochondrial Fe-S cluster synthesis.
Loss of ERG29 in respiratory cells affects Yfh1 levels
Yfh1 affects an early step in the synthesis of Fe-S clusters
within mitochondria. The observation that loss of ERG29 can
be suppressed by overexpressed YFH1 led us to examine the
levels of Yfh1 in respiring cells when ERG29 was “shut off.”
Isolation of mitochondria from erg29pGAL1ERG29 cells
grown in glucose showed a decrease in the level of Yfh1 (Fig. 7A,
lane 6), which was not due to a reduction in YFH1mRNA levels
(Fig. 7B). In fact, YFH1 transcripts were up-regulated slightly in
response to loss of Erg29, whereas ISU1 transcripts were unal-
tered. The decrease in Yfh1 proteinwas specific to Yfh1, as little
or no decrease was observed in other Fe-S cluster synthesis
proteins, including Nfs1, the cysteine desulfurase involved in
generating sulfide (37, 38); Isu1, a Fe-S scaffold protein (39);
and Ssq1, a chaperone involved in the assembly of mitochon-
drial Fe-S clusters (40, 41). Overexpression ofMMT1 or PET20
Figure 3. Loss of respiration affects the sterol pattern oferg29 cells. A, WT Rho0 anderg29 Rho0 cells were grown in CM glucose medium for 18 h, and
sterol analysis was performed as described. The data are expressed as the percentage of total sterols. Error bars, S.D. of four separate experiments. B, cells as in
Awere plated onto iron-limited medium (BPS (0–100 M iron)) and grown at 30 °C for 2 days. C, sterol analysis was performed on cells grown in iron-limited
medium (BPS(0)) for 4 h. The data are expressed as the percentage of total sterols. Error bars, S.D. of two separate experiments.D, cells as in Awere plated onto
YPDwith or without 1mM CoCl2 or YPGE and grown at 30 °C for 3 days. E, cells as in Awere plated onto CMmedium containing varying concentrations (M) of
ABP and grown at 30 °C for 2 days.
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in erg29pGAL1ERG29 cells permitted partial rescue of Yfh1
levels.We note that overexpression of PET20 affected the levels
of Isu1 in both galactose- and glucose-grown cells. We do not
know the reason for this reduction but note that the reduction
in Isu1 did not affect aconitase activity.
Loss of ERG29 leads to increasedmitochondrial oxidants
Under normal conditions, increased pools of free mitochon-
drial iron do not impose a growth deficit in cells (42). Under
conditions of stress or specific gene deletions, however, pools of
free mitochondrial iron exacerbate the generation of oxidant
radicals (43, 44). Based on those findings, we examinedwhether
loss ofERG29 led to increasedmitochondrial oxidants using the
reagent MitoSOX Red, which localizes to mitochondria and
upon oxidation becomes fluorescent. WT cells showed a low
level of mitochondrial oxidants, whereas erg29pGAL1ERG29
cells grown in glucose medium showed a dramatic increase in
mitochondrial oxidants (Fig. 7C). This increase was signifi-
cantly reduced by overexpression of YFH1,MMT1,MMT2, or
PET20. These results confirm that loss of ERG29 increases
mitochondrial oxidants and that altering mitochondrial iron
either through increased iron export or by increasing Fe-S clus-
ter synthesis reduces mitochondrial oxidants.
Loss of ERG25 affects mitochondrial activities
The finding that loss of ERG29 affects mitochondrial activi-
ties prompted us to test the effects of loss of ERG25 on mito-
chondrial activity, because both genes affect the methyl sterol
oxidase reaction. erg25pGAL1ERG25 cells grown in glucose
showed decreased aconitase activity compared with WT cells
(Fig. 8A), decreased Yfh1 levels (Fig. 8B), and increased mito-
chondrial oxidants (Fig. 8C). Neither the growth phenotype
(data not shown) nor changes in mitochondrial activity due to
“shut-off” of ERG25 could be suppressed by overexpression of
MMT1, MMT2, or YFH1. As Erg25 is an essential enzyme,
these results suggest that the effects of complete Erg25 loss
Figure 4. Library screen identifies YFH1, MMT1, MMT2, and PET20 as high-copy suppressors of the loss of ERG29. A, WT cells containing pYEp or
erg29pGAL1ERG29 cells transformed with pYEp or identified library candidates (YFH1, MMT1, MMT2, or PET20) were plated onto galactose- or glucose-
containingmedium and grown for 3 days. n 4. B, sterol analysis was performed on cells as in A, grown in glucose-containingmedium for 18 h. The data are
expressed as the percentage of total sterols. Error bars, S.D. n 3.
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cannot be overcome by simply altering mitochondrial iron lev-
els or Fe-S cluster synthesis.
Discussion
The results reported here suggest that Erg29 is involved in
sterol metabolism and that loss of Erg29 results in the genera-
tion of 4-methyl sterol metabolites. Data suggesting that Erg29
is involved in sterol metabolism include the following: 1) Erg29
is localized to the ER, where methyl sterol synthesis occurs; 2)
loss of ERG29 affects the methyl sterol oxidase reaction, result-
ing in increased levels of 4,4-DMZ and 4-methyl sterol inter-
mediates and correspondingly decreased levels of zymosterol
and ergosterol; and 3)erg29Rho0 cells aremore sensitive than
WT cells to agents that affect the methyl sterol oxidase reac-
tion. These data, most notably the accumulation of 4,4-DMZ,
the loss of zymosterol and ergosterol, and suppression by over-
expression ofERG25 point to themethyl sterol oxidase reaction
being affected inerg29 cells, although the exact role of Erg29 is
unclear. The finding that Erg29 affects the sterol pathway is
supported by data presented in large chemogenomic studies
Figure 5. Changes inmitochondrial iron levels affecterg29 growth on respiratory substrates. A, two separate clones of eithermrs3mrs4 (C1/C2) or
erg29mrs3mrs4 (E1/E2) containing a pMET3MRS3 plasmid were grown on GE-containing medium  10 Met (OFF) or Met (ON) for 5 days. n  2. B,
erg29 Rho0 cells containing pMET3, pMET3MRS3, or pMETMRS3 and pMET3MMT1 were grown in the absence of methionine for 8 h, and sterol analysis was
performed. The data are expressed as the percentage of total sterols. Error bars, S.D. of two separate experiments.
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(45, 46).Wewere unable to suppress the loss of ERG29 through
the addition of ergosterol even in cells overexpressing the Sut1
transcription factor that up-regulates sterol uptake genes (47,
48) (data not shown). Similarly, Lee et al. (46) reported that the
addition of ergosterol did not rescue the growth defect associ-
atedwith Erg29-specific inhibitors. These results suggest that it
is not the loss of ergosterol that results in toxicity but rather the
accumulation of intermediate sterols. A similar finding was
reported for loss of ERG26 or a temperature-sensitive allele of
erg26-1 in which ergosterol supplementation could not over-
come toxicity (21, 49). The exact role of Erg29 in the methyl
sterol oxidase reaction remains to be identified. We hypothe-
sized that Erg29may be acting to deliver iron to Erg25 or that it
may be a chaperone for Erg25, although extensive experimen-
tation has not shown iron bound to Erg29, and we have been
unsuccessful in co-immunoprecipitating Erg29 and Erg25 (data
not shown).
We have not identified the specific toxic sterol intermediates
generated when ERG29 is lost, but our data suggest that their
levels are affected by oxidants. Reductions in mitochondrial
respiration (Rho0), or reduction of mitochondrial iron-based
oxidants led to suppression of toxicity and at least a partial
restoration of sterol metabolism. The genetic suppressors did
not return the sterol profile to normal but did decrease the
accumulation of 4,4-DMZ and 4-methyl fecosterol. Loss of
ERG25 led to a similar constellation of phenotypes (decreased
Fe-S synthesis, increased mitochondrial oxidants, and loss of
Yfh1). These phenotypes, however, could not be suppressed by
overexpression of those genes that suppressed the erg29 phe-
notype. These results suggest that loss of Erg29 makes the
methyl sterol oxidase reaction sensitive to oxidized sterol inter-
mediates. Most of the oxidation of the sterols is due to reactive
oxygen present in the mitochondria either as a result of respi-
ration or the interaction of reactive sterolmetaboliteswith iron,
leading to a further increase in reactive oxygen. In the absence
of mitochondrial respiration (Rho0), however, other conditions
that lead to increased oxidants, such as decreased mitochon-
drial iron transport (43) or increased cobalt (23), may result in
more oxidized sterols and an attack on Fe-S clusters. Many of
the enzymes involved in Fe-S cluster synthesis are themselves
Figure 6. Loss ofYFH1or ERG29 affects Fe-S cluster synthesis.A,yfh1pMET3YFH1 cells containing empty vector or pMMT1/2were grownonCMplus (OFF)
or minus 10methionine (ON) with or without 0.00125% H2O2 or 3.0 mM iron (Fe) for 3 days. B, WT 1457 and erg29 pGAL1ERG29 cells with empty vector,
pYFH1, pMMT1, pMMT2, or pPET20were grown in glucose for 18 h, and aconitase activity wasmeasured as described under “Materials andmethods.” n 3. C,
lysates from Bwere analyzed for lipoic acid protein modification byWestern blotting as described previously (35). n 3. PDH, pyruvate dehydrogenase; KDH,
-ketogluterate dehydrogenase. The ratio of lipoic acid modification/porin was determined using Bio-Rad ImageLabTM software. Error bars, S.D.
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Fe-S cluster–containing enzymes. The nature of the genetic
suppressors identified in this study supports the model that
exporting iron through Mmt1 and Mmt2 will reduce oxidant
generation. Yfh1 may be the target for reactive oxidants, which
results in its degradation. It is also possible that YFH1 transla-
tion may be decreased, resulting in decreased levels of Yfh1
protein. We have not formally addressed this possibility in the
current studies. We found that overexpression of YFH1 results
in increased Yfh1 inmitochondria, yet it only showedmild sup-
pression of the sterol intermediate accumulation seen inerg29
cells. Itmay be that oxidizedYfh1 is functionally inactive or that
Yfh1 suppresses the erg29 phenotype by chelating iron, as
Yfh1 has been suggested to be an iron-binding protein (8, 11,
50). The function of Pet20 is unclear except that its loss
renders respiratory active yeast susceptible to a wide variety
of conditions, including H2O2 and the antifungal drug flu-
conazole (15).
In otherwise normal cells, increases in themitochondrial free
iron pool do not affect cell growth. Indeed, overexpression of
MRS3 or MRS4 can rescue the cytosolic iron lethality due to
loss of the vacuolar iron importer Ccc1 (43). To our knowledge,
it is only under conditions in which mitochondrial Fe-S cluster
synthesis is diminished that increased mitochondrial iron is
toxic. Loss of Fe-S synthesis results in the formation of iron
Figure 7. Loss of ERG29 results in decreased levels of Yfh1 protein and increasedmitochondrial oxidants. A, mitochondrial preparations fromWTpYEp,
erg29pGAL1ERG29pYEp, pMMT1, or pPET20 grown in galactose or glucose were analyzed for Yfh1, porin, Nfs1, Isu1, and Ssq1 byWestern blotting. n 2. Gels
were quantified using Bio-Rad ImageLabTM software with Yfh1 levels normalized to porin in each sample. B, mRNA was isolated from WTpYEp or erg29
pGAL1ERG29 cells grown in glucose for 16 h, and quantitative PCR was performed for YFH1 or ISU1 and ACT1 for normalization. C, cells as in Bwere incubated
with 20 nM Mitosox dye and washed, and Mitosox fluorescence was determined by flow cytometry in duplicate as described under “Materials and methods.”
n 2 separate experiments. Error bars, S.D.
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nanoparticles, presumably by an oxidation step. Reducing the
generation of ironnanoparticles by restricting the free iron pool
reduces oxidant generation and the deleterious effects of those
oxidants (11). The findings reported here all support the idea
that generation of methyl sterol metabolites results in mito-
chondrial oxidation linked to iron, which then affects the essen-
tial Fe-S cluster biosynthetic process. The generation of sterol
metabolites precedes the loss of Fe-S cluster activity, as
decreasing Fe-S cluster activity by reducing the levels of Yfh1 or
Nfs1 does not result in altered sterols (51).
Other reports show a relationship between altered sterol bio-
synthesis and mitochondrial Fe-S cluster synthesis. Flucona-
zole is an azole derivative that affects the reaction catalyzed by
Erg11 (52), an ER-localized sterol synthesis enzyme. The toxic-
ity of fluconazole is due to the generation of sterol intermedi-
ates, which can be affected bymitochondrial respiration, result-
ing in the generation of toxic 4-methyl sterol intermediates.
Most recently, Demuyser et al. (53) identified the mitochon-
drial chaperone proteinMge1 as a high-copy suppressor of flu-
conazole toxicity. Mge1 is a chaperone involved in Fe-S cluster
metabolism and protein import into the mitochondria. The
authors showed that Mge1 acted as a suppressor by increasing
ergosterol upon fluconazole treatment and that the suppressive
effect of Mge1 overexpression was lost in cells that had a dele-
tion in the Fe-S chaperone encoded by SSQ1, pointing again to
involvement of Fe-S synthesis in the toxicity of fluconazole.
The finding that Yfh1 and Fe-S cluster synthesis may be a
target for mitochondrial oxidants may extend to agents other
than sterolmetabolites and to species other than yeast. It is well
established that doxorubicin-induced cardiac toxicity is due to
the generation of iron-related oxidants (54, 55). Expression of
mitochondrial ferritin can protect HeLa cells from doxorubicin
toxicity (56), and mice with a targeted gene deletion in mito-
chondrial ferritin are much more sensitive to doxorubicin-me-
diated cardiac toxicity than normal mice (57). Ardehali and
colleagues (58) reported that overexpression of Abcb8, a mito-
chondrial ATP transporter, reduced doxorubicin-mediated
toxicity. The substrate transported out of the mitochondria by
Abcb8 was a Fe-GSH conjugate, although the exact compound
was unclear. Recently, Mouli et al. (59) reported that doxorubi-
cin induced the loss of Fe-S cluster synthesis by reducing the
levels of frataxin in cultured cardiac myocytes due to increased
degradation. They also showed that overexpression of frataxin
prevents doxorubicin toxicity. Overexpression of frataxin in
transgenic flies suppressed the effects of iron, H2O2, and para-
quat on lifespan (60). Further studies demonstrated that a puri-
fied recombinant cell-permeable frataxin (PEP1-frataxin) pro-
tected neuronal cells from oxidant-mediated cell death (61).
The effects of the Parkinson’s disease-inducing neurotoxin
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which targets
complex I in the electron transport chain, can be suppressed by
overexpression of ferritin or through increased levels of frataxin
due to administration of Tat-frataxin (62). These results under-
score that mitochondria are highly susceptible to iron-medi-
ated toxicity and suggest that this toxicity may target Fe-S clus-
ter formation. The data also suggest that frataxin may be a
central target for oxidants either due to its specific role in Fe-S
cluster synthesis or as an iron-bindingmolecule. Based on these
findings, we speculate that other compounds that result in
mitochondrial toxicity, through generation of reactive oxygen
radicals, might also attack Fe-S cluster synthesis and be sup-
pressed by either removal of mitochondrial iron or increased
levels of frataxin.
Figure 8. Loss of ERG25 results in decreased Fe-S synthesis and
decreased Yfh1. A, WT anderg25pGAL1ERG25 cells were grown in glucose-
containingmedium for 16 h, and aconitase activity wasmeasured. n 2with
two separate clones per experiment. B, mitochondrial lysates from cells as in
A grown in galactose or glucosewere analyzed for Yfh1, porin, Nfs1, Isu1, and
Ssq1by Western blotting. Gels were quantified using Bio-Rad ImageLabTM
software with Yfh1 levels normalized to porin in each sample. C,
erg25pGAL1ERG25 containing pYEp, pMMT1, pMMT2, or pYFH1 grown in
galactose or glucose for 16 h was incubated with 20 nM Mitosox dye and
washed, and Mitosox fluorescence was determined by flow cytometry in
duplicate as described under “Materials and methods.” n 2.
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Materials andmethods
Yeast, plasmids, and growthmedium
Genotypes of strains employed in this study are listed in
Table 1. TheWT strains employed for these experiments were
from theW303 background.Most deletion strainswere created
by either PCR amplifying the KanMX cassette from the
homozygous diploid deletion collection (Research Genetics) or
fusion PCR (63). Cells were grown in YPD (1% yeast extract, 2%
peptone, 2% dextrose), YPGE (2% glycerol/ethanol), CM (0.67%
yeast nitrogen base, 0.12% drop-out amino acid mixture, 2%
dextrose), CMwith 2% galactose or 2% glycerol/ethanol. Media
were made iron-deficient by the addition of 80 M BPS, and
specific concentrations of ferrous sulfate (M)were added back.
The concentration of added iron in M is denoted as BPS(x).
Plasmids used in this study are listed in Table 2. Strains with
-estradiol–regulated expression plasmids consist of a Gal4
fused to an estrogen-responsive VP16 activation domain
expressed from the MRP7 promoter as described (20) and a
plasmid with a GAL1 promoter driving expression of ERG29 or
ERG25. To induce ERG25 or ERG29 expression, cells were
grown in 50 nM -estradiol-containing (Sigma) or galactose-
containing medium. APB was added to growth medium at var-
ious concentrations, or cobalt chloride (CoCl2, 1.0 mM) was
added to growth medium. Cells were grown for 2–4 days on
plates and overnight in liquid medium.
Suppressor library screen
erg29 cells containing pYCpERG29 URA3 were trans-
formed with a high-copy YEp-LEU2 genomic library. Colonies
were selected on uracilleucine. Colonies were replicated
onto 5-fluoroorotic acid to allow loss of theURA3 ERG29 plas-
mid, and colonies were plated onto YPGE. Colonies positive for
growth on YPGE were identified, genomic preparations were
made, and rescued plasmids were sequenced and identified
genes subcloned to determine the gene(s) responsible for sup-
pression. To confirm suppression of the poor growthdue to loss
of ERG29erg29pGAL1ERG29 (TRP1), cells were transformed
with pYFH1, pMMT1, pMMT2, or pPET20 (LEU2 plasmids),
and growth on CMtrpleuhis galactose or glucose was
assessed.
Sterol analysis
Cells were grown in galactose-containingmediumovernight,
shifted to glucose-containing medium for 18 h, pelleted,
washed, and frozen at 80 °C. Lipid extractions were per-
formed on frozen cell pellets as described (64). All GC/MS
sterol analysis was performed with an Agilent 7200 gas chro-
matograph-mass spectrometer fit with an Agilent 7693A
autosampler (Agilent Technologies, Santa Clara, CA). Dried
samples were suspended in 40 l of pyridine, followed by
transfer to autosampler vials, and 80 l of N-methyl-N-tri-
methylsilyltrifluoracetamide (Thermo Fisher) was added auto-
matically via the autosampler and incubated for 30min at 37 °C
with shaking. After incubation, 1l of the prepared sample was
injected into the gas chromatograph inlet in the splitmodewith
the inlet temperature held at 250 °C. A 25:1 split ratio was used
for analysis. The gas chromatograph had an initial temperature
of 60 °C for 1min followed by a 10 °C/min ramp to 325 °C and a
hold time of 2 min. A 30-m Agilent Zorbax DB-5MS with a
10-mDuraguard capillary columnwas employed for chromato-
graphic separation. Helium was used as the carrier gas at a rate
of 1 ml/min. Data were collected using MassHunter software
(Agilent). Metabolites were identified, and their peak area was
recorded using MassHunter Quant. These data were trans-
ferred to an Excel spreadsheet (Microsoft Corp., Redmond,
WA).
MitoSOX flow cytometry
erg29pGAL1ERG29 plus or minus suppressor-identified
plasmids was grown in galactose-containing medium over-
night, shifted to glucose-containing medium for 16–18 h, and
incubated with 20 nM MitoSOX according to the manufactu-
rer’s instructions (Thermo Fisher), and fluorescence was
detected using a BDFACSCanto running FACSDiva version 8.0
software.
Other procedures and reagents
Quantitative PCR primers for YFH1, ISU1, and ACT1 were
YFH1 forward GTCCAGCTGTAACAAATAAAA and reverse
GTGCAATTTCTTAACGAAACCC, ISU1 forward CAAGA-
AACGTCGGCTCATTA and reverse GTCCAAGGTCATC-
CCCTGTA, and ACT1 forward TGTCACCAACTGGG-
ACGATA and reverse GGCTTGGATGGAAACGTAGA.
Differential interference contrast and epifluorescence images
were captured using an Olympus BX51 microscope with a
100, 1.3 numerical aperture oil immersion objective and Pic-
tureframer software. Aconitase activity was determined as
described previously (42). For mitochondrial isolations, cells
were digested and homogenized, crude mitochondrial pellets
were obtained by centrifugation at 10,000 g for 10min,mem-
Table 2
Yeast strains used in this study
Strain Genotype Source/Reference
DY1457 ura3-52, leu2-3,112, trp1-1, his3-11, 15, ade6, can1-100(oc) Ref. 42
DY150 ura3-52, leu2-3, 112, trp1-1, ade2-1, can1-100(oc) Ref. 42
erg29p-estradiol (pGEV)pGAL1ERG29 ura3-52, leu2-3,112, trp1-1, his3-11, 15, ade6, can1-100(oc)
erg29::KanMX4 p-estradiol-pGAL1ERG29–6XHIS
This study
erg25p-estradiol (pGEV)pGAL1ERG25 ura3-52, leu2-3,112, trp1-1, his3-11, 15, ade6, can1–100(oc)
erg25::KanMX4 p-estradiol-pGAL1-ERG25–6XHIS
This study
DY1457 Rho0 ura3-52, leu2-3,112, trp1-1, his3-11, 15, ade6, can1-100(oc) This study
erg29 Rho0 ura3-52, leu2-3,112, trp1-1, his3-11, 15, ade6, can1-100(oc) erg29::KanMX4 This study
yfh1MET3YFH1 ura3-52, leu2-3, 112, trp1-1, ade2-1, can1-100(oc), yfh1::HIS3 Refs. 5 and 51
mrs3mrs4 ura3-52, leu2-3, 112, trp1-1, ade2-1, can1-100(oc), mrs3mrs4::KAN Refs. 42, 67, and 68
mrs3mrs4erg29 ura3-52, leu2-3, 112, trp1-1, ade2-1, can1-100(oc), erg29::HIS3, mrs3mrs4::KAN This study
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branes were solubilized, and protein determinations were per-
formed as described previously (65). Proteins were analyzed by
4–20% SDS-PAGETris/glycine followed byWestern blot anal-
ysis using Western Lightning (PerkinElmer Life Sciences).
Antisera used for probing Western blots included rabbit anti-
His6 (1:1000), rabbit anti-Erg25 (1:500), rabbit anti-Yfh1
(1:1000), rabbit anti-Nfs1 (1:1000), rabbit anti-Isu1 (1:1000),
rabbit anti-Ssq1 (1:1000), or mouse anti-porin (1:1000). Sec-
ondary antibodieswere either peroxidase-conjugated goat anti-
rabbit IgG or peroxidase-conjugated goat anti-mouse IgG
(Jackson ImmunoResearch Laboratories; 1:5000). Western
blots were quantified using Bio-Rad ImageLabTM software.
Cells were made Rho0 by incubating them in the presence of
ethidium bromide overnight. Statistical analyses were per-
formed using a two-tailed Student’s t test with significance set
at p 0.05 (*), 0.01 (**), 0.001 (***), and 0.0001 (****).
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